Pediatric Cancer: Clinical Trials

24 trials for Pediatric Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 recruiting, 6 terminated, 5 completed, 2 not yet recruiting. 24 Phase 1, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 124Recruiting 7, Terminated 6, Completed 5, Not yet recruiting 2, Unknown 2, Active not recruiting 1, Withdrawn 1
Phase 29Recruiting 5, Active not recruiting 1, Not yet recruiting 1, Terminated 1, Withdrawn 1

Follow Pediatric Cancer: new trials by email Literature Review of Pediatric Cancer trials Research Report on Pediatric Cancer

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
sonrotoclax, Azacitidine, Inotuzumab ozogamicin - Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
Phase 1 / Phase 2Not yet recruitingBeOne Medicines302026-12-012026-10-26
Study of Zanzalintinib in Children and Adolescents With Relapsed or Refractory Solid Tumors
Zanzalintinib - Cancer, Pediatric Cancer
Phase 1Not yet recruitingExelixis182026-09-302026-08-19
Virtual Reality Gaming for Exercise and Mindfulness Among Pediatric Cancer Rehabilitation
Immediate Start - Virtual Reality, Delayed Start - Virtual Reality - Pediatric Cancer
Phase 1CompletedUniversity of Alabama at Birmingham112024-06-272026-03-18
Effectiveness of Pucotenlimab Combined With Standard Chemotherapy Regimen
Pucotenlimab - Rhabdomyosarcoma, Pediatric Cancer
Phase 1 / Phase 2RecruitingSun Yat-sen University822024-06-062024-06-13
Lurbinectedin in FET-Fused Tumors
Lurbinectedin - Ewing Sarcoma, Desmoplastic Small Round Cell Tumor
Phase 1 / Phase 2RecruitingChildren's Hospital of Philadelphia632023-07-272026-09-02
Curcumin VS Photo-bio-modulation Therapy of Oral Mucositis in Pediatric Patients Undergoing Anti-Cancer Non-invasive Treatment
Curcumin, Laser - Oral Mucositis, Pediatric Cancer
Phase 1CompletedRiyadh Elm University902023-03-152024-08-05
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Atezolizumab, Sorafenib, Bevacizumab - Refractory Solid Tumor, Hepatocellular Carcinoma
Phase 1 / Phase 2RecruitingSt. Jude Children's Research Hospital642022-11-072026-05-19
Uproleselan With Pre-Transplant Conditioning in Hematopoietic Stem Cell Transplantation for AML
Uproleselan, Fludarabine, Clofarabine - Acute Myeloid Leukemia, Pediatric Cancer
Phase 1TerminatedMalika Kapadia12022-10-062024-08-19
TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide
Temozolomide Oral Suspension - Pediatric Cancer
Phase 1CompletedOrphelia Pharma492021-03-162025-07-31
A Pilot Randomized Controlled Trial for Feasibility of Administering an AR Game to Postoperative Pediatric Cancer Patients
ARISE with AR, ARISE without AR - Pediatric Cancer, Surgery
Phase 1UnknownALTality, Inc.202021-01-132021-08-16
Sintilimab in the Treatment of Advanced and Refractory Pediatric Malignant Tumors
Sintilimab - Pediatric Cancer
Phase 1UnknownSun Yat-sen University182020-08-112020-09-03
Phase I Study of Marizomib + Panobinostat for Children With DIPG
Marizomib, Panobinostat - Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma
Phase 1TerminatedDana-Farber Cancer Institute42020-08-102024-02-15
Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid Tumors
administration of a propranolol (HEMANGIOL®) and oral metronomic vinorelbine (NAVELBINE®) combination - Pediatric Cancer
Phase 1RecruitingAssistance Publique Hopitaux De Marseille542020-08-032026-11-12
9-ING-41 in Pediatric Patients With Refractory Malignancies.
9-ING-41, Irinotecan, Temozolomide - Refractory Cancer, Refractory Neoplasm
Phase 1TerminatedActuate Therapeutics Inc.402020-06-052025-07-17
A Phase I, First in Human Study of CBA-1205, Anti-DLK1 Monoclonal Antibody in Patients With Advanced Solid Tumors, Hepatocellular Carcinoma (HCC), Melanoma, and Pediatric Cancer
CBA-1205 Part 1, CBA-1205 Part 2, CBA-1205 Part 3 - Solid Tumors, Hepatocellular Carcinoma (HCC)
Phase 1RecruitingChiome Bioscience Inc.662020-06-012026-06-17
Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia
Intravenous fluids - Lymphoma, Acute Lymphoblastic Leukemia
Phase 1CompletedVirginia Commonwealth University102019-10-022024-02-13
Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma
Famitinib, Ifosfamide, Camrelizumab - Effect of Drugs, Progression
Phase 1 / Phase 2WithdrawnPeking University People's Hospital2019-08-152020-05-19
A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
Tranexamic Acid, Normal saline - Pediatric Cancer, Thrombocytopenia
Phase 1 / Phase 2TerminatedMeghan McCormick112019-04-222021-09-20
Durvalumab and Tremelimumab for Pediatric Malignancies
Durvalumab / Tremelimumab Combination Therapy - Pediatric Cancer, Solid Tumor Pediatric
Phase 1 / Phase 2Active not recruitingAstraZeneca502019-03-072026-09-29
Radiotherapy Delivery in Deep Inspiration for Pediatric Patients
radiotherapy delivery in deep-inspiration - Pediatric Cancer
Phase 1 / Phase 2RecruitingCopenhagen University Hospital, Rigshospitalet252017-01-012020-10-09

Showing 20 of 24. Sign in to see all of them.

Narrower conditions

Neoplasms (24)  ·  Carcinoma, Hepatocellular (3)  ·  Neuroblastoma (3)  ·  Recurrence (3)  ·  Diffuse Intrinsic Pontine Glioma (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Lymphoma (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Rhabdomyosarcoma (2)  ·  Sarcoma, Ewing (2)  ·  Brain Neoplasms (1)  ·  Burkitt Lymphoma (1)  ·  Desmoplastic Small Round Cell Tumor (1)  ·  Disease Progression (1)  ·  Fibrolamellar hepatocellular carcinoma (1)

Broader conditions

Neoplasms by Histologic Type (13)  ·  Neoplasms by Site (7)  ·  Hemic and Lymphatic Diseases (6)  ·  Neoplasms, Glandular and Epithelial (6)  ·  Neoplasms, Nerve Tissue (6)  ·  Neuroectodermal Tumors (6)  ·  Hematologic Diseases (5)  ·  Neoplasms, Germ Cell and Embryonal (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Disease Attributes (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Adenocarcinoma (3)  ·  Brain Diseases (3)  ·  Carcinoma (3)

Interventions

Cyclophosphamide (3)  ·  Dexamethasone (2)  ·  Irinotecan (2)  ·  Temozolomide (2)  ·  Topotecan (2)  ·  Vinorelbine (2)  ·  3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1)  ·  AZD 6244 (1)  ·  Azacitidine (1)  ·  Bevacizumab (1)  ·  Busulfan (1)  ·  CYC065 (1)  ·  Calcium Dobesilate (1)  ·  Carboplatin (1)  ·  Clofarabine (1)

Sponsors

Sun Yat-sen University (2)  ·  ALTality, Inc. (1)  ·  Actuate Therapeutics Inc. (1)  ·  AeRang Kim (1)  ·  Assistance Publique Hopitaux De Marseille (1)  ·  AstraZeneca (1)  ·  BeOne Medicines (1)  ·  Children's Hospital of Philadelphia (1)  ·  Chiome Bioscience Inc. (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Dana-Farber Cancer Institute (1)  ·  Exelixis (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  Malika Kapadia (1)  ·  Meghan McCormick (1)

Countries

United States (12)  ·  France (4)  ·  China (3)  ·  Netherlands (3)  ·  Spain (3)  ·  United Kingdom (3)  ·  Denmark (2)  ·  Germany (2)  ·  Italy (2)  ·  Finland (1)  ·  Japan (1)  ·  Saudi Arabia (1)  ·  Sweden (1)

Top investigators

AeRang Kim, MD, PhD (1)  ·  Amanda Linz, MD (1)  ·  Ashok Gupta, MD, PhD (1)  ·  Birgit Geoerger, MD (1)  ·  Cady P Noda, PharmD (1)  ·  Christina York (1)  ·  Jae Eun Choi (1)  ·  Jamie Sinton, MD (1)  ·  Jessica Gartrell, MD (1)  ·  Juan Cata, MD (1)  ·  Katherine Warren, MD (1)  ·  Malika Kapadia, MD (1)  ·  Meghan McCormick, MD (1)  ·  Per Kogner, Professor (1)

Results publications

PMID 24327518, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29587881, PMID 29846250, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31538815, PMID 31831767, PMID 31882719, PMID 32005489, PMID 33892407, PMID 34347542, PMID 34533416, PMID 34543871, PMID 35292802, PMID 37828033, PMID 39714090, PMID 39832211, PMID 39868759, PMID 41838385, PMID 42222420, PMID 42686334

NIH funding

2016 (1), 2018 (1), 2023 (1), R42DA050365 (1)